The recognised conditions are type 2 diabetes, prediabetes, high blood pressure, high cholesterol or dyslipidaemia (an unhealthy balance of fats in the blood), cardiovascular disease, and obstructive sleep apnoea 1,2
53 Future Directions and Unanswered Questions Despite recent evidence from clinical trials, key questions remain about the optimal use of GLP-1RAs for HF
Meanwhile, biomarker testing company Superpowers AI-powered Concierge takes your lab test results and metabolic history into account when recommending supplements such as vitamin D, protein and amino acids, magnesium glycinate and other products
is supported by the National Institutes of Health grants R01AG059008, R01AG073212 and P30AG072980, as well as by the Barrow Neurological Foundation
Laura Choi, a weight-loss surgeon and weight-loss specialist, about what someone can expect when they stop taking weight-loss medication